CClinicalTrials.gg
CompletedNCT01566214VHPIUpdated Dec 24, 2018Results posted

Vet-Harts Pilot Intervention for Veterans With Coronary Heart Disease

A Phase 2 interventional study of Motivational Interview in Heart Disease, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-12-24.

Sponsored by VA Office of Research and Development · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research study is to survey patients to learn about their beliefs and behaviors related to the management of heart disease and to discuss options for making healthy lifestyle changes. From the information the investigators get from patients, the investigators hope to develop better methods for taking care of patients who have heart disease.

Read the detailed description

Coronary heart disease (CHD) is a significant health threat among veterans. Compared to their civilian counterparts, veterans experience greater disability, reinfarction, and mortality following myocardial infarction (MI) and other acute coronary syndromes (ACS). High rates of hypertension, diabetes, and cardiac risk behaviors (e.g., smoking) and low socioeconomic status (SES) further increase veterans' CHD-related morbidity and mortality. The proposed pilot project will establish the feasibility of a telehealth nursing intervention for veterans with CHD who are recovering from MI/ACS. The Veterans Heart Attack Representations Telehealth (Vet-HART) intervention is designed to promote adaptive conceptual change in veterans' beliefs (common sense models or representations) about CHD etiology and self-management and facilitate health behavior changes (e.g., smoking cessation, medication adherence, diet management, and increased physical activity). The long-term goal of this research program is to improve veterans' quality of life (QoL) and reduce their CHD-related morbidity/mortality. The proposed project is the requisite next step in attaining that goal.

02

Conditions studied

  • Heart Disease

Browse trials for

Keywords

  • coronary heart disease (CHD)
  • myocardial infarction (MI)
  • acute coronary syndromes (ACS)
03

In context

Heart Diseases

3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.

This study's enrollment of 12 is below the median of 100 across 1,778 interventional studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Admission to an inpatient medicine unit for MI, ACS, and coronary angiography
  • Age

Exclusion criteria

Exclusion Criteria:

  • Altered mental status
  • Language barriers
  • Dementia or Cognitive Impairment
  • Diagnostic Study
  • Resident in long-term care facility prior to the present admission
  • Planned discharge to a skilled or intermediate care facility or hospice
  • Lack of access to a functioning phone
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Motivational Interview

    For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes.

    Behavioral: Motivational Interview

  • No intervention
    Usual Care

    For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.

Interventions

  • BehavioralMotivational Interview

    For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes.

06

What researchers measure

Primary outcomes

  1. SF-36v Physical Function Scale

    Physical Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  2. SF-36v Role Limitations Due to Physical Health Scale

    Role Limitations Due to Physical Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  3. SF-36v Role Limitations Due to Emotional Problems Scale

    Role Limitations Due to Emotional Problems Scale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  4. SF-36v Energy-Fatigue Scale

    Energy-Fatigue Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  5. SF-36v Emotional Well-Being Scale

    Emotional Well-Being Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  6. SF-36v Social Functioning Scale

    Social Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  7. SF-36v Pain Scale

    Pain Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  8. SF-36v General Health Scale

    General Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  9. Seattle Angina Questionnaire Physical Limitations Scale

    Physical Limitations Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  10. Seattle Angina Questionnaire Angina Stability Scale

    Angina Stability Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  11. Seattle Angina Questionnaire Angina Frequency Scale

    Angina Frequency Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  12. Seattle Angina Questionnaire Treatment Satisfaction Scale

    Treatment Satisfaction Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

  13. Seattle Angina Questionnaire Disease Perception Scale

    Disease Perception Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Time frame: Change from baseline to 3-months post hospital discharge

07

Results

Posted Dec 24, 2018

Participant flow

Participant flow — Overall Study
MilestoneMotivational InterviewUsual Care
Started66
Completed36
Not completed30
Withdrew: Lost to follow-up30

Outcome measures

PrimarySF-36v Physical Function Scale

Physical Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
SF-36v Physical Function Scale
units on a scaleMotivational InterviewUsual Care
SF-36v Physical Function Scale-6.67 ± 7.6413.33 ± 12.52
PrimarySF-36v Role Limitations Due to Physical Health Scale

Role Limitations Due to Physical Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
SF-36v Role Limitations Due to Physical Health Scale
units on a scaleMotivational InterviewUsual Care
SF-36v Role Limitations Due to Physical Health Scale-22.92 ± 35.549.38 ± 36.39
PrimarySF-36v Role Limitations Due to Emotional Problems Scale

Role Limitations Due to Emotional Problems Scale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
SF-36v Role Limitations Due to Emotional Problems Scale
units on a scaleMotivational InterviewUsual Care
SF-36v Role Limitations Due to Emotional Problems Scale-27.78 ± 25.465.56 ± 13.61
PrimarySF-36v Energy-Fatigue Scale

Energy-Fatigue Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
SF-36v Energy-Fatigue Scale
units on a scaleMotivational InterviewUsual Care
SF-36v Energy-Fatigue Scale-5.00 ± 42.651.67 ± 23.49
PrimarySF-36v Emotional Well-Being Scale

Emotional Well-Being Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
SF-36v Emotional Well-Being Scale
units on a scaleMotivational InterviewUsual Care
SF-36v Emotional Well-Being Scale-14.67 ± 37.86-2.00 ± 7.90
PrimarySF-36v Social Functioning Scale

Social Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
SF-36v Social Functioning Scale
units on a scaleMotivational InterviewUsual Care
SF-36v Social Functioning Scale-16.67 ± 40.18-10.42 ± 18.40
PrimarySF-36v Pain Scale

Pain Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
SF-36v Pain Scale
units on a scaleMotivational InterviewUsual Care
SF-36v Pain Scale-5.00 ± 13.2314.17 ± 13.10
PrimarySF-36v General Health Scale

General Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
SF-36v General Health Scale
units on a scaleMotivational InterviewUsual Care
SF-36v General Health Scale-5.00 ± 18.034.17 ± 17.15
PrimarySeattle Angina Questionnaire Physical Limitations Scale

Physical Limitations Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
Seattle Angina Questionnaire Physical Limitations Scale
units on a scaleMotivational InterviewUsual Care
Seattle Angina Questionnaire Physical Limitations Scale-5.93 ± 8.983.33 ± 30.43
PrimarySeattle Angina Questionnaire Angina Stability Scale

Angina Stability Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
Seattle Angina Questionnaire Angina Stability Scale
units on a scaleMotivational InterviewUsual Care
Seattle Angina Questionnaire Angina Stability Scale25.00 ± 66.14-12.50 ± 17.68
PrimarySeattle Angina Questionnaire Angina Frequency Scale

Angina Frequency Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
Seattle Angina Questionnaire Angina Frequency Scale
units on a scaleMotivational InterviewUsual Care
Seattle Angina Questionnaire Angina Frequency Scale20.00 ± 43.5916.67 ± 22.51
PrimarySeattle Angina Questionnaire Treatment Satisfaction Scale

Treatment Satisfaction Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
Seattle Angina Questionnaire Treatment Satisfaction Scale
units on a scaleMotivational InterviewUsual Care
Seattle Angina Questionnaire Treatment Satisfaction Scale-3.92 ± 33.457.84 ± 10.95
PrimarySeattle Angina Questionnaire Disease Perception Scale

Disease Perception Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Time frame:
Change from baseline to 3-months post hospital discharge
Reported as:
Mean · units on a scale
Seattle Angina Questionnaire Disease Perception Scale
units on a scaleMotivational InterviewUsual Care
Seattle Angina Questionnaire Disease Perception Scale13.89 ± 9.629.72 ± 17.01

Adverse events

Collected over 3 Months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Motivational Interview0/6 (0%)0/6 (0%)0/6 (0%)
Usual Care0/6 (0%)0/6 (0%)0/6 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Motivational InterviewUsual CareTotal
Mean68.33 ± 11.9865.67 ± 8.6467.00 ± 10.05
Sex: Female, Male
Sex: Female, Male(Participants)Motivational InterviewUsual CareTotal
Female000
Male6612
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Motivational InterviewUsual CareTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American000
White314
More than one race000
Unknown or Not Reported358
Region of Enrollment
Region of Enrollment(participants)Motivational InterviewUsual CareTotal
United States6612
08

Study locations

1 site
  • Iowa City VA Health Care System, Iowa City, IA
    Iowa City, Iowa 52246-2208, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 24, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01566214
Lead sponsor
VA Office of Research and Development
Collaborators
University of Iowa
Responsible party
Sponsor
First posted
Mar 29, 2012
Start date
Apr 30, 2012
Primary completion
Jun 30, 2012
Completion
Oct 31, 2012
Results posted
Dec 24, 2018
Last update
Dec 24, 2018

Study contacts

Mark W Vander Weg, PhD MS BA
principal investigator · Iowa City VA Health Care System, Iowa City, IA

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion